Comparison of contrast-enhanced CT, dual-layer detector spectral CT, and whole-body MRI in suspected metastatic breast cancer: a prospective diagnostic accuracy study

2021 ◽  
Author(s):  
Thomas Winther Buus ◽  
Finn Rasmussen ◽  
Hanne Marie Nellemann ◽  
Vibeke Løgager ◽  
Anders Bonde Jensen ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Metastatic Breast ◽  
Whole Body ◽  
Diagnostic Accuracy Study ◽  
Spectral Ct ◽  
Whole Body Mri ◽  
Contrast Enhanced Ct ◽  
Contrast Enhanced ◽  
Enhanced Ct ◽  
Accuracy Study

Detection of distant metastases in rectal cancer: contrast-enhanced CT vs whole body MRI

2020 ◽  
Vol 31 (1) ◽  
pp. 104-111
Author(s):  
Jeong Hee Yoon ◽  
Mi Hye Yu ◽  
Bo Yun Hur ◽  
Chang Min Park ◽  
Jeong Min Lee
Keyword(s):  
Rectal Cancer ◽  
Distant Metastases ◽  
Whole Body ◽  
Whole Body Mri ◽  
Contrast Enhanced Ct ◽  
Contrast Enhanced ◽  
Enhanced Ct

Can diffusion-weighted whole-body MRI replace contrast-enhanced CT for initial staging of Hodgkin lymphoma in children and adolescents?

2018 ◽  
Vol 48 (5) ◽  
pp. 638-647 ◽  
Author(s):  
Rodrigo Regacini ◽  
Andrea Puchnick ◽  
Flavio Augusto Vercillo Luisi ◽  
Henrique Manoel Lederman
Keyword(s):  
Children And Adolescents ◽  
Hodgkin Lymphoma ◽  
Whole Body ◽  
Whole Body Mri ◽  
Diffusion Weighted ◽  
Contrast Enhanced Ct ◽  
Contrast Enhanced ◽  
Enhanced Ct ◽  
Initial Staging

scholarly journals Comparison of FDG-PET/CT and contrast-enhanced CT for monitoring therapy response in patients with metastatic breast cancer

2017 ◽  
Vol 44 (9) ◽  
pp. 1428-1437 ◽  
Author(s):  
Christopher C. Riedl ◽  
Katja Pinker ◽  
Gary A. Ulaner ◽  
Leonard T. Ong ◽  
Pascal Baltzer ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Metastatic Breast Cancer ◽  
Metastatic Breast ◽  
Therapy Response ◽  
Contrast Enhanced Ct ◽  
Monitoring Therapy ◽  
Contrast Enhanced ◽  
Pet Ct ◽  
Enhanced Ct ◽  
Fdg Pet Ct

scholarly journals Whole-Body Magnetic Resonance Imaging: Current Role in Patients with Lymphoma

Diagnostics ◽  
2021 ◽  
Vol 11 (6) ◽  
pp. 1007
Author(s):  
Domenico Albano ◽  
Giuseppe Micci ◽  
Caterina Patti ◽  
Federico Midiri ◽  
Silvia Albano ◽  
...  
Keyword(s):  
Whole Body ◽  
Resonance Imaging ◽  
Whole Body Mri ◽  
Contrast Enhanced Ct ◽  
Contrast Enhanced ◽  
Pet Ct ◽  
Enhanced Ct ◽  
Body Magnetic Resonance Imaging ◽  
18F Fdg ◽  
Fdg Pet Ct

Imaging of lymphoma is based on the use of 18F-fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG-PET/CT) and/or contrast-enhanced CT, but concerns have been raised regarding radiation exposure related to imaging scans in patients with cancer, and its association with increased risk of secondary tumors in patients with lymphoma has been established. To date, lymphoproliferative disorders are among the most common indications to perform whole-body magnetic resonance imaging (MRI). Whole-body MRI is superior to contrast-enhanced CT for staging the disease, also being less dependent on histology if compared to 18F-FDG-PET/CT. As well, it does not require exposure to ionizing radiation and could be used for the surveillance of lymphoma. The current role of whole-body MRI in the diagnostic workup in lymphoma is examined in the present review along with the diagnostic performance in staging, response assessment and surveillance of different lymphoma subtypes.

Nuklearmedizinische Untersuchung verbessert Erfolgskontrolle in der Brustkrebsbehandlung

2018 ◽  
Vol 50 (01) ◽  
pp. 17-20
Author(s):  
Trine Jørgensen
Keyword(s):  
Breast Cancer ◽  
Metastatic Breast Cancer ◽  
Metastatic Breast ◽  
Therapy Response ◽  
Contrast Enhanced Ct ◽  
Monitoring Therapy ◽  
Contrast Enhanced ◽  
Pet Ct ◽  
Enhanced Ct ◽  
Fdg Pet Ct

Riedl CC, Pinker K, Ulaner GA, Ong LT, Baltzer P, Jochelson MS, McArthur HL, Gönen M, Dickler M, Weber WA. Comparison of FDG-PET/CT and contrast-enhanced CT for monitoring therapy response in patients with metastatic breast cancer. Eur J Nucl Med Mol Imaging 2017; doi: 10.1007/s00259-017-3703-7 Eine PET/CT-Untersuchung kann den Erfolg einer Brustkrebstherapie besser vorhersagen als eine Computertomographie (CT) allein. Dies belegt eine neue Studie mit 145 Patientinnen, die an fortgeschrittenem Brustkrebs litten. Demnach könnte das nuklearmedizinisch-radiologische Kombi-Verfahren den Therapieverlauf bei jeder vierten Brustkrebspatientin beeinflussen.

scholarly journals Viable tumor tissue detection in murine metastatic breast cancer by whole-body MRI and multispectral analysis

2009 ◽  
Vol 62 (6) ◽  
pp. 1423-1430 ◽  
Author(s):  
Kai H. Barck ◽  
Brandon Willis ◽  
Jed Ross ◽  
Dorothy M. French ◽  
Ellen H. Filvaroff ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Metastatic Breast Cancer ◽  
Tumor Tissue ◽  
Metastatic Breast ◽  
Whole Body ◽  
Whole Body Mri ◽  
Viable Tumor ◽  
Viable Tumor Tissue ◽  
Multispectral Analysis

Discrepancy between FDG-PET/CT and contrast-enhanced CT in the staging of patients with inflammatory breast cancer: implications for treatment planning

2020 ◽  
Vol 181 (2) ◽  
pp. 383-390 ◽  
Author(s):  
Heather A. Jacene ◽  
Pamela J. DiPiro ◽  
Jennifer Bellon ◽  
Jiani Hu ◽  
Su-Chun Cheng ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Treatment Planning ◽  
Inflammatory Breast Cancer ◽  
Fdg Pet ◽  
Contrast Enhanced Ct ◽  
Contrast Enhanced ◽  
Pet Ct ◽  
Enhanced Ct ◽  
Fdg Pet Ct

68Ga-PSMA-PET/CT in comparison with 18F-fluoride-PET/CT and whole-body MRI for the detection of bone metastases in patients with prostate cancer: a prospective diagnostic accuracy study

2018 ◽  
Vol 29 (3) ◽  
pp. 1221-1230 ◽  
Author(s):  
Eva Dyrberg ◽  
Helle W. Hendel ◽  
Tri Hien Viet Huynh ◽  
Tobias Wirenfeldt Klausen ◽  
Vibeke B. Løgager ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Diagnostic Accuracy ◽  
Bone Metastases ◽  
Whole Body ◽  
Diagnostic Accuracy Study ◽  
Whole Body Mri ◽  
Psma Pet ◽  
Pet Ct ◽  
Accuracy Study ◽  
18F Fluoride
Sign in / Sign up

Export Citation Format

Share Document